264
Views
7
CrossRef citations to date
0
Altmetric
Short Communication

Risk factors and clinical outcome of profound thrombocytopenia in adult patients with DENV infections

, , , , , , & show all
Pages 724-727 | Received 13 Aug 2016, Accepted 31 Jan 2017, Published online: 13 Mar 2017

References

  • WHO. Dengue guidelines for diagnosis, treatment, prevention and control. 3rd edn. Geneva: World Health Organization; 2009.
  • Yong YK, Thayan R, Chong HT, Tan CT, Sekaran SD. Rapid detection and serotyping of dengue virus by multiplex RT-PCR and real-time SYBR green RT-PCR. Singapore Med J 2007;48(7):662–668.
  • Venkata C, Kashyap R, Farmer JC, Afessa B. Thrombocytopenia in adult patients with sepsis: Incidence, risk factors, and its association with clinical outcome. J Intensive Care 2013;1(1):9.
  • Lye DC, Lee VJ, Sun Y, Leo YS. Lack of efficacy of prophylactic platelet transfusion for severe thrombocytopenia in adults with acute uncomplicated dengue infection. Clin Infect Dis 2009;48(9):1262–1265.
  • Lee IK, Liu JW, Yang KD. Fatal dengue hemorrhagic fever in adults: Emphasizing the evolutionary pre-fatal clinical and laboratory manifestations. PLoS Negl Trop Dis 2012;6(2): e1532.
  • Thomas L, Brouste Y, Najioullah F, Hochedez P, Hatchuel Y, Moravie V, et al. Predictors of severe manifestations in a cohort of adult dengue patients. J Clin Virol 2010;48(2):96–99.
  • Dhanoa A, Hassan SS, Ngim CF, Lau CF, Chan TS, Adnan NA, Eng WW, Gan HM, Rajasekaram G. Impact of dengue virus (DENV) coinfection on clinical manifestations, disease severity and laboratory parameters. BMC Infect Dis 2016;16(1):406.
  • Wong JG, Thein TL, Leo YS, Pang J, Lye DC. Identifying adult dengue patients at low risk for clinically significant bleeding. PLoS One 2016;11(2): e0148579.
  • Chaurasia R, Zaman S, Chatterjee K, Das B. Retrospective review of platelet transfusion practices during 2013 dengue epidemic of Delhi, India. Transfus Med Hemother 2015;42(4):227–231
  • Chen CY, Lee MY, Lin KD, Hsu WH, Lee YJ, Hsiao PJ, Shin SJ. Diabetes mellitus increases severity of thrombocytopenia in dengue-infected patients. Int J Mol Sci 2015;16(2):3820–3830.
  • Mourão MP1, Lacerda MV, Macedo VO, Santos JB. Thrombocytopenia in patients with dengue virus infection in the Brazilian Amazon. Platelets 2007;18(8):605.
  • Krishnamurti C, Kalayanarooj S, Cutting MA, Peat RA, Rothwell SW, Reid TJ, et al. Mechanisms of hemorrhage in dengue without circulatory collapse. Am J Trop Med Hyg 2001;65(6):840–847
  • Libraty DH1, Endy TP, Houng HS, Green S, Kalayanarooj S, Suntayakorn S, et al. Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections. J Infect Dis 2002;185(9):1213–1221.
  • Lum LC, Goh AY, Chan PW, El-Amin AL, Lam SK. Risk factors for hemorrhage in severe dengue infections. J Pediatr 2002;140(5):629–631.
  • de Azeredo EL, Monteiro RQ, de-Oliveira Pinto LM. Thrombocytopenia in dengue: Interrelationship between virus and the imbalance between coagulation and fibrinolysis and inflammatory mediators. Mediators Inflamm 2015;2015:313842.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.